Sangani Hospitals Ltd

Sangani Hospitals Ltd

₹ 41.0 0.00%
24 Sep - close price
About

Incorporated in 2021, Sangani Hospitals is in the business of Hospital, Laboratory, and Pharmacy[1]

Key Points

Business Overview:[1][2]
SHL is in the business of Hospitals, pathological laboratory and Pharmacy stores. It operates 2 hospitals viz. Sangani Hospital at Keshod, Gujarat, and Sangani Super Speciality Hospital, Veraval, Gujarat. It also operates 2 pathology laboratories and 2 medical stores.

  • Market Cap 56.5 Cr.
  • Current Price 41.0
  • High / Low 49.2 / 35.2
  • Stock P/E 20.9
  • Book Value 24.3
  • Dividend Yield 0.00 %
  • ROCE 14.1 %
  • ROE 10.5 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Debtor days have improved from 106 to 53.4 days.
  • Company's working capital requirements have reduced from 56.2 days to 37.6 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Mar 2023 Sep 2023 Mar 2024
5.85 5.80 5.98 6.25
4.42 4.20 4.26 4.86
Operating Profit 1.43 1.60 1.72 1.39
OPM % 24.44% 27.59% 28.76% 22.24%
0.00 0.09 0.09 0.72
Interest 0.00 0.00 0.00 0.00
Depreciation 0.28 0.79 0.13 0.16
Profit before tax 1.15 0.90 1.68 1.95
Tax % 25.22% 73.33% 39.29% 13.85%
0.86 0.24 1.03 1.67
EPS in Rs 0.86 0.24 0.75 1.21
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
4.20 11.66 12.24
2.75 8.57 9.14
Operating Profit 1.45 3.09 3.10
OPM % 34.52% 26.50% 25.33%
0.00 0.03 0.82
Interest 0.00 0.00 0.00
Depreciation 0.06 1.07 0.28
Profit before tax 1.39 2.05 3.64
Tax % 25.18% 24.88% 25.55%
1.04 1.53 2.70
EPS in Rs 2.63 1.53 1.96
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 5%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 71%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 2%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
Equity Capital 3.95 9.99 13.78
Reserves 1.04 8.01 19.71
0.03 0.00 0.00
1.62 1.22 1.49
Total Liabilities 6.64 19.22 34.98
0.86 11.87 12.67
CWIP 0.00 0.00 0.00
Investments 0.00 0.81 0.84
5.78 6.54 21.47
Total Assets 6.64 19.22 34.98

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
2.25 3.31
-12.84 -1.11
11.45 12.42
Net Cash Flow 0.86 14.62

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
Debtor Days 203.36 60.73 53.38
Inventory Days 160.09 48.98 92.54
Days Payable 448.25 85.32 128.52
Cash Conversion Cycle -84.80 24.39 17.39
Working Capital Days 88.64 42.26 37.57
ROCE % 18.33% 14.14%

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Jun 2024
72.48% 73.22% 73.22%
0.00% 0.02% 0.02%
27.52% 26.76% 26.76%
No. of Shareholders 555457433

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents